Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells

Cytokine

Volumn 63, Issue 2, 2013, Pages 151-165

  Buckner, Lyndsey R ^a   Lewis, Maria E ^a   Greene, Sheila J ^a   Foster, Timothy P ^a   Quayle, Alison J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chlamydia; Cytokine; Endocervix; Epithelial; Immune

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 11; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; IP10 PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASOLATERAL MEMBRANE; CELL MATURATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE RELEASE; DEVELOPMENTAL STAGE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; UTERINE CERVIX EPITHELIUM;

CELL LINE; CERVIX UTERI; CHEMOKINE CCL5; CHEMOKINES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTOKINES; EPITHELIAL CELLS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-11; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; INTERLEUKIN-8; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-1; TUMOR NECROSIS FACTOR-ALPHA;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIAE;

EID: 84878978879     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.04.022     Document Type: Article

References (95)

1. Brunham R.C., Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005, 5(2):149-161.
2. Golden M.R., Schillinger J.A., Markowitz L., St Louis M.E. Duration of untreated genital infections with Chlamydia trachomatis: a review of the literature. Sex Transm Dis 2000, 27(6):329-337.
3. Joyner J.L., Douglas J.M., Foster M., Judson F.N. Persistence of Chlamydia trachomatis infection detected by polymerase chain reaction in untreated patients. Sex Transm Dis 2002, 29(4):196-200.
4. Molano M., Meijer C.J., Weiderpass E., Arslan A., Posso H., Franceschi S., et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 2005, 191(6):907-916.
5. Morre S.A., van den Brule A.J., Rozendaal L., Boeke A.J., Voorhorst F.J., de Blok S., et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002, 13(Suppl. 2):12-18.
6. Parks K.S., Dixon P.B., Richey C.M., Hook E.W. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997, 24(4):229-235.
7. Hybiske K., Stephens R.S. Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci USA 2007, 104(27):11430-11435.
8. Moulder J.W. Interaction of chlamydiae and host cells in vitro. Microbiol Rev 1991, 55(1):143-190.
9. Dessus-Babus S., Moore C.G., Whittimore J.D., Wyrick P.B. Comparison of Chlamydia trachomatis serovar L2 growth in polarized genital epithelial cells grown in three-dimensional culture with non-polarized cells. Microbes Infect 2008, 10(5):563-570.
10. Wyrick P.B., Gerbig D.G., Knight S.T., Raulston J.E. Accelerated development of genital Chlamydia trachomatis serovar E in McCoy cells grown on microcarrier beads. Microb Pathog 1996, 20(1):31-40.
11. Buckner L.R., Schust D.J., Ding J., Nagamatsu T., Beatty W., Chang T.L., et al. Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix. J Reprod Immunol 2011, 92(1-2):8-20.
12. Herbst-Kralovetz M.M., Quayle A.J., Ficarra M., Greene S., Rose W.A., Chesson R., et al. Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am J Reprod Immunol 2008, 59(3):212-224.
13. Nair A., Venkatraman M., Maliekal T.T., Nair B., Karunagaran D. NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 2003, 22(1):50-58.
14. Landry J, Pyl PT, Rausch T, Tekkedil MM, Stuetz AM, Jauch A, Aiyar RS, Pau G, Delhomme N, Gagneur J, Korbel JO, Huber W, Steinmetz LM. The genomic and transcriptomic landscape of a HeLa cell line. G3; 2013.
15. Rasmussen S.J., Eckmann L., Quayle A.J., Shen L., Zhang Y.X., Anderson D.J., et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997, 99(1):77-87.
16. Stephens R.S. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003, 11(1):44-51.
17. Kane C.D., Vena R.M., Ouellette S.P., Byrne G.I. Intracellular tryptophan pool sizes may account for differences in gamma interferon-mediated inhibition and persistence of chlamydial growth in polarized and nonpolarized cells. Infect Immun 1999, 67(4):1666-1671.
18. Wyrick P. Polarized epithelial cell culture for Chlamydia trachomatis. In: Wyrick P, Bavoil P, editors. Chlamydia genomics and pathogenesis. Norfolk (UK): Horizon Bioscience; 2006. p. 323-38.
19. Frohlich K., Hua Z., Wang J., Shen L. Isolation of Chlamydia trachomatis and membrane vesicles derived from host and bacteria. J Microbiol Methods 2012, 91(2):222-230.
20. Belland R.J., Nelson D.E., Virok D., Crane D.D., Hogan D., Sturdevant D., et al. Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc Natl Acad Sci USA 2003, 100(26):15971-15976.
21. Beatty W.L. Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis. J Cell Sci 2006, 119(Pt 2):350-359.
22. Tremellen K.P., Seamark R.F., Robertson S.A. Seminal transforming growth factor beta1 stimulates granulocyte-macrophage colony-stimulating factor production and inflammatory cell recruitment in the murine uterus. Biol Reprod 1998, 58(5):1217-1225.
23. Sun J., Schoborg R.V. The host adherens junction molecule nectin-1 is degraded by chlamydial protease-like activity factor (CPAF) in Chlamydia trachomatis-infected genital epithelial cells. Microbes Infect 2009, 11(1):12-19.
24. de la Torre E., Mulla M.J., Yu A.G., Lee S.J., Kavathas P.B., Abrahams V.M. Chlamydia trachomatis infection modulates trophoblast cytokine/chemokine production. J Immunol 2009, 182(6):3735-3745.
25. Giles D.K., Whittimore J.D., LaRue R.W., Raulston J.E., Wyrick P.B. Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion. Microbes Infect 2006, 8(6):1579-1591.
26. Buchholz K.R., Stephens R.S. The extracellular signal-regulated kinase/mitogen-activated protein kinase pathway induces the inflammatory factor interleukin-8 following Chlamydia trachomatis infection. Infect Immun 2007, 75(12):5924-5929.
27. Mpiga P., Mansour S., Morisset R., Beaulieu R., Ravaoarinoro M. Sustained interleukin-6 and interleukin-8 expression following infection with Chlamydia trachomatis serovar L2 in a HeLa/THP-1 cell co-culture model. Scand J Immunol 2006, 63(3):199-207.
28. Dessus-Babus S., Darville T.L., Cuozzo F.P., Ferguson K., Wyrick P.B. Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis. Infect Immun 2002, 70(6):3234-3248.
29. Fahey J.V., Schaefer T.M., Channon J.Y., Wira C.R. Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum Reprod 2005, 20(6):1439-1446.
30. Fichorova R.N., Anderson D.J. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 1999, 60(2):508-514.
31. O'Connell C.M., Ionova I.A., Quayle A.J., Visintin A., Ingalls R.R. Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen. J Biol Chem 2006, 281(3):1652-1659.
32. Eckmann L., Kagnoff M.F., Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 1993, 61(11):4569-4574.
33. Beatty W.L., Byrne G.I., Morrison R.P. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 1993, 90(9):3998-4002.
34. Ibana J.A., Schust D.J., Sugimoto J., Nagamatsu T., Greene S.J., Quayle A.J. Chlamydia trachomatis immune evasion via downregulation of MHC class I surface expression involves direct and indirect mechanisms. Infect Dis Obstet Gynecol 2011, 2011:420905.
35. Kawana K., Quayle A.J., Ficarra M., Ibana J.A., Shen L., Kawana Y., et al. CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activity. J Biol Chem 2007, 282(10):7368-7375.
36. Lad S.P., Li J., da Silva Correia J., Pan Q., Gadwal S., Ulevitch R.J., et al. Cleavage of p65/RelA of the NF-kappaB pathway by Chlamydia. Proc Natl Acad Sci USA 2007, 104(8):2933-2938.
37. Le Negrate G., Krieg A., Faustin B., Loeffler M., Godzik A., Krajewski S., et al. ChlaDub1 of Chlamydia trachomatis suppresses NF-kappaB activation and inhibits IkappaBalpha ubiquitination and degradation. Cell Microbiol 2008, 10(9):1879-1892.
38. Zhong G., Fan T., Liu L. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J Exp Med 1999, 189(12):1931-1938.
39. Zhong G., Liu L., Fan T., Fan P., Ji H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in Chlamydia-infected cells. J Exp Med 2000, 191(9):1525-1534.
40. Wang J., Frohlich K.M., Buckner L., Quayle A.J., Luo M., Feng X., et al. Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells. Microbiology 2011, 157(Pt 10):2759-2771.
41. Christian J., Vier J., Paschen S.A., Hacker G. Cleavage of the NF-kappaB family protein p65/RelA by the chlamydial protease-like activity factor (CPAF) impairs proinflammatory signaling in cells infected with Chlamydiae. J Biol Chem 2010, 285(53):41320-41327.
42. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappa B. Ann Rev Cell Biol 1994, 10:405-455.
43. Ingalls R.R., Rice P.A., Qureshi N., Takayama K., Lin J.S., Golenbock D.T. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 1995, 63(8):3125-3130.
44. Cheng W., Shivshankar P., Zhong Y., Chen D., Li Z., Zhong G. Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infect Immun 2008, 76(3):942-951.
45. Hirsiger S., Simmen H.P., Werner C.M., Wanner G.A., Rittirsch D. Danger signals activating the immune response after trauma. Med Inflamm 2012, 2012:315941.
46. Hallegua D.S., Weisman M.H. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis 2002, 61(11):960-967.
47. Arend W.P., Guthridge C.J. Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis 2000, 59(Suppl. 1):60-64.
48. Skwor T.A., Atik B., Kandel R.P., Adhikari H.K., Sharma B., Dean D. Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease, PLoS Negl. Trop Dis 2008, 2(7):e264.
49. Perrier S., Kherratia B., Deschaumes C., Ughetto S., Kemeny J.L., Baudet-Pommel M., et al. IL-1ra and IL-1 production in human oral mucosal epithelial cells in culture: differential modulation by TGF-beta1 and IL-4. Clin Exp Immunol 2002, 127(1):53-59.
50. Levine S.J., Wu T., Shelhamer J.H. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids. J Immunol 1997, 158(12):5949-5957.
51. Derbigny W.A., Hong S.C., Kerr M.S., Temkit M., Johnson R.M. Chlamydia muridarum infection elicits a beta interferon response in murine oviduct epithelial cells dependent on interferon regulatory factor 3 and TRIF. Infect Immun 2007, 75(3):1280-1290.
52. Johnson R.M. Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect Immun 2004, 72(7):3951-3960.
53. Nelson D.E., Virok D.P., Wood H., Roshick C., Johnson R.M., Whitmire W.M., et al. Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc Natl Acad Sci USA 2005, 102(30):10658-10663.
54. Quayle A.J. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol 2002, 57(1-2):61-79.
55. Wira C.R., Grant-Tschudy K.S., Crane-Godreau M.A. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am J Reprod Immunol 2005, 53(2):65-76.
56. Hvid M., Baczynska A., Deleuran B., Fedder J., Knudsen H.J., Christiansen G., et al. Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection. Cell Microbiol 2007, 9(12):2795-2803.
57. Kavathas P.B., Boeras C.M., Mulla M.J., Abrahams V.M. Nod1, but not the ASC inflammasome, contributes to induction of IL-1beta secretion in human trophoblasts after sensing of Chlamydia trachomatis. Mucosal Immunol 2013, 6(2):235-243.
58. Davis C.H., Wyrick P.B. Differences in the association of Chlamydia trachomatis serovar E and serovar L2 with epithelial cells in vitro may reflect biological differences in vivo. Infect Immun 1997, 65(7):2914-2924.
59. Klein W., Tromm A., Griga T., Fricke H., Folwaczny C., Hocke M., et al. A polymorphism in the IL11 gene is associated with ulcerative colitis. Genes Immun 2002, 3(8):494-496.
60. Dorner A.J., Goldman S.J., Keith J.C. Interleukin-11. BioDrugs 1997, 8(6):418-429.
61. Putoczki T., Ernst M. More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer. J Leukoc Biol 2010, 88(6):1109-1117.
62. Janeway C.A., Travers P., Walport M., Shlomchik M.J. Immunobiology: the immune system in health and disease 2005, Garland Science Publishing, New York (NY). 6th ed.
63. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998, 101(4):746-754.
64. Ramsey K.H., Rank R.G. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun 1991, 59(3):925-931.
65. Rank R.G., Soderberg L.S., Barron A.L. Chronic chlamydial genital infection in congenitally athymic nude mice. Infect Immun 1985, 48(3):847-849.
66. Beatty W.L., Belanger T.A., Desai A.A., Morrison R.P., Byrne G.I. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun 1994, 62(9):3705-3711.
67. Beatty W.L., Belanger T.A., Desai A.A., Morrison R.P., Byrne G.I. Role of tryptophan in gamma interferon-mediated chlamydial persistence. Ann NY Acad Sci 1994, 730:304-306.
68. Tseng C.T., Rank R.G. Role of NK cells in early host response to chlamydial genital infection. Infect Immun 1998, 66(12):5867-5875.
69. Rank R.G., Bowlin A.K., Kelly K.A. Characterization of lymphocyte response in the female genital tract during ascending Chlamydial genital infection in the guinea pig model. Infect Immun 2000, 68(9):5293-5298.
70. Igietseme J.U., Wyrick P.B., Goyeau D., Rank R.G. An in vitro model for immune control of chlamydial growth in polarized epithelial cells. Infect Immun 1994, 62(8):3528-3535.
71. Prantner D., Sikes J.D., Hennings L., Savenka A.V., Basnakian A.G., Nagarajan U.M. Interferon regulatory transcription factor 3 protects mice from uterine horn pathology during Chlamydia muridarum genital infection. Infect Immun 2011, 79(10):3922-3933.
72. Wolf K., Fields K.A. Chlamydia pneumoniae impairs the innate immune response in infected epithelial cells by targeting TRAF3. J Immunol 2013, 190(4):1695-1701.
73. Hiersche H.D., Nagl W. Regeneration of secretory epithelium in the human endocervix. Arch Gynecol 1980, 229(2):83-90.
74. Rodel J., Grosse C., Yu H., Wolf K., Otto G.P., Liebler-Tenorio E., et al. Persistent Chlamydia trachomatis infection of HeLa cells mediates apoptosis resistance through a Chlamydia protease-like activity factor-independent mechanism and induces high mobility group box 1 release. Infect Immun 2012, 80(1):195-205.
75. Sharma M., Machuy N., Bohme L., Karunakaran K., Maurer A.P., Meyer T.F., et al. HIF-1alpha is involved in mediating apoptosis resistance to Chlamydia trachomatis-infected cells. Cell Microbiol 2011, 13(10):1573-1585.
76. Ying S., Christian J.G., Paschen S.A., Hacker G. Chlamydia trachomatis can protect host cells against apoptosis in the absence of cellular inhibitor of apoptosis proteins and Mcl-1. Microbes Infect 2008, 10(1):97-101.
77. Ying S., Pettengill M., Ojcius D.M., Hacker G. Host-cell survival and death during Chlamydia infection. Curr Immunol Rev 2007, 3(1):31-40.
78. Carlson J.H., Porcella S.F., McClarty G., Caldwell H.D. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect Immun 2005, 73(10):6407-6418.
79. Fehlner-Gardiner C., Roshick C., Carlson J.H., Hughes S., Belland R.J., Caldwell H.D., et al. Molecular basis defining human Chlamydia trachomatis tissue tropism. A possible role for tryptophan synthase. J Biol Chem 2002, 277(30):26893-26903.
80. McClarty G., Caldwell H.D., Nelson D.E. Chlamydial interferon gamma immune evasion influences infection tropism. Curr Opin Microbiol 2007, 10(1):47-51.
81. Ibana J.A., Myers L., Porretta C., Lewis M., Taylor S.N., Martin D.H., et al. The major CD8 T cell effector memory subset in the normal and Chlamydia trachomatis-infected human endocervix is low in perforin. BMC Immunol 2012, 13:66.
82. Koehler L., Nettelnbreker E., Hudson A.P., Ott N., Gerard H.C., Branigan P.J., et al. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog 1997, 22(3):133-142.
83. Yong E.C., Chi E.Y., Kuo C.C. Differential antimicrobial activity of human mononuclear phagocytes against the human biovars of Chlamydia trachomatis. J Immunol 1987, 139(4):1297-1302.
84. Ibana J.A., Belland R.J., Zea A.H., Schust D.J., Nagamatsu T., AbdelRahman Y.M., et al. Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells. Infect Immun 2011, 79(11):4425-4437.
85. Reveneau N., Crane D.D., Fischer E., Caldwell H.D. Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis. Antimicrob Agents Chemother 2005, 49(5):1787-1793.
86. Ibana J.A., Aiyar A., Quayle A.J., Schust D.J. Modulation of MICA on the surface of Chlamydia trachomatis-infected endocervical epithelial cells promotes NK cell-mediated killing. FEMS Immunol Med Microbiol 2012, 65(1):32-42.
87. Givan A.L., White H.D., Stern J.E., Colby E., Gosselin E.J., Guyre P.M., et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 1997, 38(5):350-359.
88. Pudney J., Quayle A.J., Anderson D.J. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 2005, 73(6):1253-1263.
89. Guseva N.V., Dessus-Babus S.C., Whittimore J.D., Moore C.G., Wyrick P.B. Characterization of estrogen-responsive epithelial cell lines and their infectivity by genital Chlamydia trachomatis. Microbes Infect 2005, 7(15):1469-1481.
90. Guseva N.V., Knight S.T., Whittimore J.D., Wyrick P.B. Primary cultures of female swine genital epithelial cells in vitro: a new approach for the study of hormonal modulation of Chlamydia infection. Infect Immun 2003, 71(8):4700-4710.
91. Maslow A.S., Davis C.H., Choong J., Wyrick P.B. Estrogen enhances attachment of Chlamydia trachomatis to human endometrial epithelial cells in vitro. Am J Obstet Gynecol 1988, 159(4):1006-1014.
92. Wand H., Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS 2012, 26(3):375-380.
93. Sharkey D.J., Macpherson A.M., Tremellen K.P., Robertson S.A. Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol Hum Reprod 2007, 13(7):491-501.
94. Robertson S.A., Ingman W.V., O'Leary S., Sharkey D.J., Tremellen K.P. Transforming growth factor beta-a mediator of immune deviation in seminal plasma. J Reprod Immunol 2002, 57(1-2):109-128.
95. Morrison R.P. New insights into a persistent problem - chlamydial infections. J Clin Invest 2003, 111(11):1647-1649.